NCT07656389 · NOT YET RECRUITING

An AI-Based Prediction of Cognitive Capacity in Older Adults and Individuals With Mild Cognitive Impairment During Virtual Reality Driving Tasks

This study uses virtual reality driving simulations combined with eye-tracking and arm-movement sensors to build an AI tool that detects early signs of cognitive decline. Researchers will compare how older adults with and without mild cognitive impairment navigate complex driving scenarios, then train an AI model to flag cognitive risk from those movement patterns. There is no phase designation — this is an observational research study, not a drug or treatment trial.

You may qualify if

  • (1) a score of 23 or higher on the Montreal Cognitive Assessment; (2) a Clinical Dementia Rating score of 0 for cognitively healthy participants or 0.5 for participants with mild cognitive impairment (MCI); (3) healthy young adults aged between 30 and 39 years, and cognitively healthy older adults and participants with MCI aged between 65 and 85 years; (4) right-hand dominance; and (5) adequate visual function to complete VR and eye-tracking tasks, defined as corrected binocular visual acuity of at least 0.5 without severe visual field deficits.

You're excluded if

  • (1) the presence or history of major psychiatric disorders or central nervous system diseases; (2) significant ocular diseases, such as untreated cataracts, active retinal diseases, moderate-to-severe or poorly controlled glaucoma, or marked visual field deficits beyond a specified level; (3) epilepsy; and (4) severe dizziness or VR-induced motion sickness.

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2026-06-18

View full record on ClinicalTrials.gov

All APOE4 clinical trials